[{"Assets_0_Q2_USD":65436000.0,"CommonStockSharesOutstanding_0_Q2_shares":17640951.0,"EarningsPerShareBasic_1_Q2_USD":-0.45,"EarningsPerShareBasic_2_Q2_USD":-0.66,"EarningsPerShareDiluted_1_Q2_USD":-0.45,"EarningsPerShareDiluted_2_Q2_USD":-0.66,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-13757000.0,"NetIncomeLoss_1_Q2_USD":-7801000.0,"NetIncomeLoss_2_Q2_USD":-11556000.0,"StockholdersEquity_0_Q2_USD":50621000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":14306491.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":16055456.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":14306491.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":16055456.0,"Ticker":"XENE","CIK":"1582313","name":"XENON PHARMACEUTICALS INC.","OfficialName":"Xenon Pharmaceuticals Inc. Common Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1764405075.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]